# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Winston Churchill (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET001-SYN
- Date: 2026-07-01
- Fictional facility: St. Posthumous Health Center
- Fictional author: Beatrice Okafor, MD
- Calendar frame: modern shifted

## Reason for visit

Primary care transition visit eight days after a minor ischemic stroke. **S**

## Historical basis

- Winston Churchill was born on 30 November 1874 at Blenheim Palace, Oxfordshire, and died in London on 24 January 1965. He was Prime Minister from 1940 to 1945 and from 1951 to 1955, when poor health forced him to resign. **D**
- In December 1941, during a visit to the White House, Churchill developed dull chest pain after opening a window with great effort. His physician interpreted it as a heart attack, but a cardiologist found no evidence of heart disease, and a later review judges the symptoms probably musculoskeletal. **R**
- His most critical episode of pneumonia was in December 1943 in Tunis; it was treated with sulfonamides, which proved effective. **D**
- Churchill had his first stroke in 1949, a less serious attack in August 1949 while staying at Cap d'Ail that his physician described as spasm of a small artery. He was seen on multiple occasions from 1950 to 1952 for further cerebrovascular episodes, including transient ischemic attacks. **D**
- On the evening of 23 June 1953, while hosting a dinner at 10 Downing Street, Churchill had a stroke consisting of a left hemiparesis, with sagging of the left side of the mouth and impaired articulation. The deficit was greatest about three days after onset, then fluctuated and gradually recovered; the course is consistent with a small lacunar infarct. **D**
- The 1953 stroke was concealed at the time: no member of the Cabinet noticed anything wrong at the dinner, and nothing about it was published until Churchill mentioned it about a year later. It has not been a secret since his physician's account was published in 1966. **D**
- During the convalescence he was described as very despondent, with spells of apathy, and he wept readily when moved, for example by poetry. **D**
- His physician diagnosed clinical depression, which became accepted lore as Churchill's "black dog"; the 2020 study by Vale and Scadding argues convincingly against this diagnosis. **R**
- Smoking and alcohol were long-standing risk factors. A 1943 fluid chart listed champagne 10 oz, brandy 2 oz, and whisky and soda 8 oz, and accounts of the 1953 convalescence describe his usual cigar and whisky and soda. **D**
- His father, Lord Randolph Churchill, died in 1895 aged 45 after a progressive illness with speech and hearing problems, dizziness, palpitations, and numbness of the hands and feet. Syphilis was long assumed; a brain tumor has been argued as more likely, and the cause cannot be determined with certainty. **R**

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- Wants to return to full work and to give a major speech within about three months. **S**
- Fears another stroke, but does not want to give up cigars or his drinking habits entirely. **S**

## Strengths and supports

- Supports: married and lives with his spouse; adult children; a large, devoted staff **S**

## Medications and allergies

- Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily for 21 days with clopidogrel **S**
- Clopidogrel 75 mg oral tablet, one tablet by mouth daily (after a 300 mg loading dose in the hospital) **S**
- Atorvastatin 80 mg oral tablet, one tablet by mouth daily **S**
- Amlodipine 5 mg oral tablet, one tablet by mouth daily **S**
- Amlodipine 10 mg oral tablet, one tablet by mouth daily **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- December 1941: Chest pain at the White House after straining to open a window; read at the time as a heart attack, but no heart disease was found and the episode was probably musculoskeletal (disputed) **R** (CLM-0002)
- December 1943: Critical pneumonia in Tunis, treated with sulfonamides **D** (CLM-0003)
- August 1949: First stroke, a less serious attack at Cap d'Ail described as spasm of a small artery **D** (CLM-0004)
- 1950 to 1952: Further cerebrovascular episodes, including transient ischemic attacks, from 1950 to 1952 **D** (CLM-0004)
- 23 June 1953: Stroke at a dinner at 10 Downing Street: left hemiparesis with a drooping mouth and slurred speech, worst on the third day; kept secret at the time **D** (CLM-0005, CLM-0006)

## Procedures and immunizations

- 2026-06-23 to 2026-06-23: MRI of the brain in the hospital: acute 12 mm lacunar infarct in the right internal capsule and corona radiata; chronic small-vessel white-matter changes in both hemispheres; no hemorrhage **S**
- 2026-06-23 to 2026-06-23: CT angiography of the head and neck in the hospital: no carotid, vertebral, or intracranial stenosis or occlusion **S**
- 2026-06-24 to 2026-06-24: Transthoracic echocardiography with bubble study in the hospital: normal left ventricular size and function, mild left ventricular hypertrophy, normal left atrium, no thrombus, no shunt **S**
- 2026-07-01 to 2026-07-01: 12-lead electrocardiogram: sinus rhythm 72/min, left ventricular hypertrophy by voltage, no atrial fibrillation **S**
- 2025-10-14: High-dose influenza vaccine, 2025-2026 season **S**
- 2022-11-07: Pneumococcal conjugate vaccine PCV20 **S**
- 2024-09-23: Respiratory syncytial virus vaccine, single dose **S**
- 2019-05-20: Recombinant zoster vaccine, two-dose series completed **S**
- 2018-03-12: Tdap vaccine **S**

## Family history

- father: Died in 1895 at 45 after a progressive illness with speech and hearing problems, dizziness, and numbness; cause disputed and not established in the cited source **R** (CLM-0013)

## Measurements

Sodium: 139 mmol/L; Potassium: 4.3 mmol/L; Creatinine: 0.98 mg/dL; eGFR: 79 mL/min/1.73 m²; Glucose: 97 mg/dL; Hemoglobin: 14.2 g/dL; Platelets: 245 10*3/uL; HbA1c: 5.5%; ALT: 30 U/L; NIH Stroke Scale: 2; MoCA: 26; PHQ-9: 8; AUDIT-C: 8. All results are synthetic.

BP 152/86 mmHg; pulse 72 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 96% on room air; weight 80 kg; BMI 28.3 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert, articulate, and quick-witted; speech mildly slurred in long sentences at intake; Mood low at times since the stroke, with apathy and poor sleep; tears up readily when moved by poetry or music, more than before; denies thoughts of death or self-harm; PHQ-9 8, item 9 scored 0. Functional status: Walks with a stick outdoors; left hand clumsy with buttons and writing; independent in self-care with extra time; modified Rankin Scale about 2 at intake; Walking without a stick, writing normally, and back at full work by about three months; modified Rankin Scale 1. Physical examination is intentionally limited. **S**

## Assessment

1. Mild left hemiparesis and dysarthria after a right-hemisphere lacunar infarct eight days before intake; synthetic modern episode linked to the documented 1953 stroke; status draft. **S**
2. Essential hypertension; status draft. **S**
3. Nicotine dependence, cigars, six to eight a day; status draft. **S**

## Plan

- Aspirin with clopidogrel for 21 days after the minor stroke, then clopidogrel 75 mg alone. Guideline: 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021); CMID: Clinical Monitoring Intelligence Database, stroke/TIA, hypertension, and depression monographs (2026) **S**
- Atorvastatin 80 mg with a lipid panel 4 to 12 weeks after starting, aiming for LDL cholesterol below 70 mg/dL. Guideline: 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021); CMID: Clinical Monitoring Intelligence Database, stroke/TIA, hypertension, and depression monographs (2026) **S**
- Neurology consultation to confirm the stroke mechanism, set the antiplatelet plan after the 21-day course, decide on prolonged cardiac rhythm monitoring, and advise on return to work and public speaking. Guideline: 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021); 2024 ACC Expert Consensus Decision Pathway on Practical Approaches for Arrhythmia Monitoring After Stroke (2024) **S**
- Outpatient physical and occupational therapy for left-sided weakness, with fall-risk review at every visit. Guideline: Primary Care of Adult Patients After Stroke: A Scientific Statement From the American Heart Association/American Stroke Association (2021); CMID: Clinical Monitoring Intelligence Database, stroke/TIA, hypertension, and depression monographs (2026) **S**
- PHQ-9 at the first visit and at each review while symptoms persist, MoCA again within the first year, and attention to post-stroke tearfulness. Guideline: Primary Care of Adult Patients After Stroke: A Scientific Statement From the American Heart Association/American Stroke Association (2021); CMID: Clinical Monitoring Intelligence Database, stroke/TIA, hypertension, and depression monographs (2026) **S**
- Brief interventions at every visit for unhealthy alcohol use (AUDIT-C, no more than two drinks a day) and cigar smoking, with nicotine replacement offered. Guideline: 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018) **S**
- Yearly influenza vaccine and current COVID-19 vaccine. Guideline: 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021); CMID: Clinical Monitoring Intelligence Database, stroke/TIA, hypertension, and depression monographs (2026) **S**

## Guideline basis

- 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack (2021), American Heart Association and American Stroke Association
- Primary Care of Adult Patients After Stroke: A Scientific Statement From the American Heart Association/American Stroke Association (2021), American Heart Association and American Stroke Association
- 2024 ACC Expert Consensus Decision Pathway on Practical Approaches for Arrhythmia Monitoring After Stroke (2024), American College of Cardiology
- Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021), U.S. Preventive Services Task Force
- Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018), U.S. Preventive Services Task Force
- CMID: Clinical Monitoring Intelligence Database, stroke/TIA, hypertension, and depression monographs (2026), Aether Forge
